Thank you for reviewing this short education presentation focusing on our upcoming LAAO Registries update to version 1.4. In this presentation, we will be reviewing facts about the update as well as going through new elements added and elements that will be retired. Here are some facts about the upgrade to version 1.4. The version 1.4 data collection tool and DQR will launch on October 4, 2022. Which means that any base procedure with a discharge date or follow-up with an assessment date on or before September 30, 2022 will still be entered in version 1.3. And any base procedure with a discharge date or follow-up with an assessment date on or after October 1, 2022 will be entered in version 1.4. Both tools are accessed through the Data tab. When it comes to data aggregation, the first aggregation of data entered in version 1.4 will be base procedure data which will take place on October 9. The first aggregation for 45-day follow-up data entered into version 1.4 will be in late October to early November. The actual date for this is yet to be determined. This will follow by the 6-month, 1-year, and 2-year follow-up data entered in version 1.4. The date for this is also to be determined. We will make an announcement when this will take place. The version 1.4 data collection tool and submit to DQR will be accessed through the Data tab. The version 1.4 data collection tool was built on a new platform that aligns our registry with the majority of NCDR registries. We would like to have everyone pay special attention to the sequence numbers in the version 1.4 upgrade. There are some sequence numbers that have stayed the same, such as the CHADS VASC and HASBLED data elements, but there are also many sequence numbers that have changed. One example is the Additional Stroke and Bleeding Risk Factors section where all of the sequence numbers have changed. The first update includes the operator name and NPI numbers, which is not a new element but was upgraded and now allows the capture of multiple providers involved or participating in the procedure. Continuing with Sequence 14732, Shared Decision Making. The registry will begin to capture the shared decision making process as documented in the medical record. If Sequence 14732 is coded Yes, Sequence 14733 will open to capture if a shared decision tool was used. If Sequence 14733 is coded Yes, Sequence 14734 will open to capture the shared decision making tool's name. We will have more information on shared decision making in the form of a KISS scenario in the coming weeks. If there is documentation that a tool was used, Sequence 14733 Shared Decision Making Tool Used will be coded Yes. If Shared Decision Making Tool Used is coded Yes, then Sequence 14734 Shared Decision Making Tool Name will become available to code, which is a drop down menu. As of now, the only option in the drop down menu is Other Shared Decision Making Tool. If there is documentation of a tool being used, please code as Other Shared Decision Making Tool. Tools are being evaluated by the registry team and will be added to the choices as appropriate. It is important to understand the shared decision making process is part of the CMS National Coverage Determination and therefore a requirement of CMS for all LAAO procedures. The registry is just capturing the documentation of the process. We have shared a few things that we know about the process in this slide. But there are some details about the process that we as a registry are not privy to. For example, who entails a non-interventional provider that should be part of this process? In the NCD, it states this provider can be the primary care provider, but does not mention if a non-interventional cardiologist, non-interventional electrophysiologist, or a physician's assistant can be part of this process. For these detailed questions, we recommend referring to your provider or local CMS representative to obtain more details of the process. Also, we advise starting communication within your facility to engage your providers for better documentation of the process. This will make it a lot easier for abstractors to capture the process in the new element. Clinically Significant Bleeding Risk was added as a choice to LAA Occlusion Indications to capture a documented indication of a patient having a significant bleeding risk without having a prior history of a major bleed. It is always good to remember the coding of this element must be based on provider documentation of the indication for this procedure. Another new element, which will be coming soon, is Sequence 15-431 to 15-436 FIT or Fellowing Training, which will capture any fellow in training participating in the procedure, their MPI number, as well as the fellowship program. A fellow in training is a medical professional who has completed their primary training, for example, that person is already an MD and is now partaking of additional training in a specialization. An MD can be a fellow in training to become a cardiologist and a cardiologist can be a fellow in training to be an interventionalist or electrophysiologist. For data collection purposes, it is important to note that an individual may be a practicing MD or cardiologist for some episodes or procedures, but a fellow in training for others at the same hospital and reporting timeframe. An individual cannot be the operator and fellow in training for the same procedure. This element will be grayed out in the data collection tool until it is ready to launch. Thank you for reviewing this presentation as we get ready to move to our new LAAO Registry Version 1.4. Thank you.

transcatheter procedures

TAVR

TMVr

TTVP

LAAO Registries

update

version 1.4

data aggregation

NCDR registries